ST2, a circulating protein marker of cardiomyocyte stress and fibrosis, which increases in patients across a wide spectrum of CVDs, is now recommended by the American College of Cardiology Foundation and American Heart Association joint guidelines for additive risk stratification in patients with HF [41]. Here, IL1RL1 is linked to hydrops fetalis.